Nitric Oxide down regulates the activity of soluble guanylyl cyclase activity
and its biologic significance
Introduction
Guanylyl cyclase (GC) is a family of enzyme that catalyze the formation of the 2nd messenger system cGMP from GTP. GC are subdivided into 2 forms, soluble guanylyl cyclase (sGC) and guanylyl cyclase that are membrane bound and linked to a receptor. Soluble guanylyl cyclase is activated by NO and membrane bound GC is activated by peptide hormones
Mammalian sGC is a heterodimer consisting of two subunits, a and b, of which there are four types (a1, a2, b1, b2). Each subunit contains a N-terminal portion, C-terminal cyclase catalytic domain and a central dimerization region. The N-terminal portion constitutes the heme-binding domain and is the least conserved re4gion of the enzyme. Both the a and b subunits are required for the biologic activity of sGC.
It has been noted that cGMP plays a role in the smooth muscle relaxation, platelet aggregation inhibition, and in retinal phosphotransduction. It was also found to participate in signal transduction within the nervous system. cGMP is also involved in regulating water and electrolyte balance as well as bone metabolism. cGMP- signalling is maediated by three different groups of cGMP effector molecules. The cGMP activated protein kinase, the cGMP- regulated phosphodiesterases, and the cGMP- gated ion channel.
Nitric oxide can be synthesized endogenously by NO synthases in a Ca2+ dependent mechanism. Stimulated sGC contains a prosthetic heme group which provides the acceptor cell for NO. NO- heme complex formation leads to a conformational change that can produce an up to 200-fold increase in the activity of the enzyme.
Two isoforms of the NO- sensitive heterodimeric enzyme have already been identified, the ubiquitous a1b1 and the less broadly distributed a2b1 isoform. Both isoforms show the same regulatory properties but differ in their subcellular distribution. It is the N- terminal of the subunit which is responsible for heme binding and heme coordination. Whereas the cyclase catalytic domains are located in the C- terminal regions. The cyclase catalytic domain is conserved in the membrane bound guanilyl cyclase as well as in the adenylyl cyclase.
Aside from NO, only a few other substances can activate sGC. Carbon monoxide has been reported to bind heme groups wit high affinity but it can only induce enzyme activity marginally, about 3 to 5- folds. An about 10- fold increase of activity has been reported for the NO sensitive GC when using YC- 1 as an activator. YC-1 also induces NO and CO sensitivity of the enzyme. It can also inhibit phosphodiesterases, thus preventing cGMP degradation.
NO is produced indogenously within the vascular endothelium and functions as a natural vasodilator. Discoverers of NO identified it as a signal molecule in the nervous system, at a weapon against infection, and as modulator of blood pressure. This discovery led to the investigation of the role of inhaled NO as a means of treating pulmonary hypertension.
The NO/ cGMP pathway controls several physiologic functions of the nervous system. the effect of NO/cGMP on the survival and differentiation of neurons and synaptic plasticity suggests that this pathway can regulate gene expression.
Wedel, BJ, Garbers DL (2001) The guanylyl cyclase family at Y2K. Annu. Rev. Physiol. 63, 215-233
Moncada S, Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 13: 1319-30
Harrison DG, Bates JN (1993) The nitrovasodilators. New ideas about old drugs. Circulation 87: 1461-1467

|
|
|